An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK.

Steve Christo-Corbis/Getty Images Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significant liver health improvements in patients.

This model keeps the liver’s natural 3D structure and mix of cells, making it a valuable way to study how diseases develop and how drugs might work. Our results were striking. Treating the liver ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic dysfunction-associated steatotic liver disease, or MASLD. The company said ...

A doctor has shared the warning signs of fatty liver disease you might not initially realise are a sign of a bigger issue. Dr Saurabh Sethi, a gastroenterologist, shares his experience and ...

For decades, the search for effective treatments for metabolic dysfunction-associated steatohepatitis (MASH) — a form of fatty liver disease — has been marked by disappointment. Despite the ...

French pharma company Genfit has reached a deal to buy Versantis of Switzerland, adding three development-stage drug candidates to its portfolio of experimental liver disease therapies and ...

Hepatitis C virus (HCV) and nonalcoholic fatty liver disease (NAFLD) are the two most common causes of chronic liver disease in North America. NAFLD represents a spectrum of liver lesions that ...

Protection against influenza-associated hospitalization conferred by vaccination was not significant among patients with liver disease, with the exception of those aged 50 to 64 years. Influenza ...